TherapeuticsMD, Inc.
NASDAQ:TXMD
1.58 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | TherapeuticsMD, Inc. |
Symbool | TXMD |
Munteenheid | USD |
Prijs | 1.58 |
Beurswaarde | 18,221,192 |
Dividendpercentage | 0% |
52-weken bereik | 1.43 - 3.07 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Governor Thomas G. Thompson |
Website | https://www.therapeuticsmd.com |
An error occurred while fetching data.
Over TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)